This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 May 3;371(9623):1501; author reply 1502.

doi: 10.1016/S0140-6736(08)60646-7.

Antipsychotics in individuals with intellectual disability

Julian N Trollor, Ernest R Somerville, Helen M Somerville

PMID: 18456092
DOI: 10.1016/S0140-6736(08)60646-7

Comment

Antipsychotics in individuals with intellectual disability

Julian N Trollor et al. Lancet. 2008.

. 2008 May 3;371(9623):1501; author reply 1502.

doi: 10.1016/S0140-6736(08)60646-7.

Authors

Julian N Trollor, Ernest R Somerville, Helen M Somerville

PMID: 18456092
DOI: 10.1016/S0140-6736(08)60646-7

No abstract available

PubMed Disclaimer

Comment on

Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial.
Tyrer P, Oliver-Africano PC, Ahmed Z, Bouras N, Cooray S, Deb S, Murphy D, Hare M, Meade M, Reece B, Kramo K, Bhaumik S, Harley D, Regan A, Thomas D, Rao B, North B, Eliahoo J, Karatela S, Soni A, Crawford M. Tyrer P, et al. Lancet. 2008 Jan 5;371(9606):57-63. doi: 10.1016/S0140-6736(08)60072-0. Lancet. 2008. PMID: 18177776 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science